Lipicure Gold 20 Capsule is a combination medication containing Aspirin (75mg), Atorvastatin (20mg), and Clopidogrel (75mg), formulated to manage and reduce the risk of cardiovascular events in patients with established atherosclerotic cardiovascular disease or those at high risk. Aspirin acts as an antiplatelet agent by irreversibly inhibiting cyclooxygenase, thereby reducing thromboxane A2 production and preventing platelet aggregation. Clopidogrel, another antiplatelet agent, selectively inhibits the ADP receptor on platelet cell membranes, further decreasing platelet activation and aggregation. Atorvastatin, a statin class drug, inhibits HMG-CoA reductase, the key enzyme in cholesterol biosynthesis, leading to significant reductions in low-density lipoprotein cholesterol (LDL-C) and overall lipid levels. The combined effect of these agents helps in preventing the formation of blood clots, reducing the risk of myocardial infarction, stroke, and other ischemic events, while also managing dyslipidemia. Lipicure Gold 20 is indicated for secondary prevention in patients with coronary artery disease, recent myocardial infarction, or stroke, and in those with hyperlipidemia requiring aggressive lipid-lowering therapy. Use should be guided by a healthcare professional, considering potential contraindications such as bleeding disorders, liver dysfunction, or hypersensitivity to any component. Regular monitoring of liver function, lipid profile, and bleeding parameters is recommended during therapy.